Search Results - "Siamak Kazemi-Asl"

Recent Advances in the Fabrication of Nano-aptasensors for the Detection of Troponin as a Main Biomarker of Acute Myocardial Infarction by Kazemi Asl, Siamak, Rahimzadegan, Milad

“…Acute myocardial infarction (AMI) as the one of the main health threatening refers to reduced blood flow to the myocardium resulting in higher proportion of…”
Get full text

Pharmacogenomics-based systematic review of coronary artery disease based on personalized medicine procedure by Kazemi Asl, Siamak, Rahimzadegan, Milad, Kazemi Asl, Alireza

“…Coronary artery disease (CAD) is the most common reason for mortality and disability-adjusted life years (DALYs) lost globally. This study aimed to suggest a…”
Get full text

The recent advancement in the chitosan hybrid-based scaffolds for cardiac regeneration after myocardial infarction by Kazemi Asl, Siamak, Rahimzadegan, Milad, Ostadrahimi, Rahman

“…Acute myocardial infarction (AMI), which cut down blood flow to the myocardium, is a serious health-threatening disorder that causes remarkable morbidity and…”
Get full text

Independence of Centers of Excellence for Medical Sciences: A Qualitative Study by Kazemi Asl, Siamak, Jaberi, Azita, Safarpour, Ali Reza, Reza Farrokhi, Majid Reza, Zarshenas, Ladan, Mehrabi, Manoosh

“…Background: Centers of Excellence are organizations which have prominent works in a specific field, and are capable of delivering quality services using…”
Get full text

The recent progress in the early diagnosis of acute myocardial infarction based on myoglobin biomarker: Nano-aptasensors approaches by Asl, Siamak Kazemi, Rahimzadegan, Milad

“…•Acute myocardial infarction (AMI) is one of the serious cardiovascular diseases (CVDs) causes of the high death percentage.•Myoglobin (Mb) has been considered…”
Get full text

Progress in cardiac tissue engineering and regeneration: Implications of gelatin-based hybrid scaffolds by Asl, Siamak Kazemi, Rahimzadegan, Milad, Asl, Alireza Kazemi

“…Cardiovascular diseases, particularly myocardial infarction (MI), remain a leading cause of morbidity and mortality worldwide. Current treatments for MI, more…”
Get full text

Glucosinolates in cancer prevention and treatment: experimental and clinical evidence by Orouji, Neda, Asl, Siamak Kazemi, Taghipour, Zahra, Habtemariam, Solomon, Nabavi, Seyed Mohammad, Rahimi, Roja

“…Glucosinolates are naturally occurring β-d-thioglucosides that mainly exist in the Brassicaceae family. The enzyme myrosinase hydrolyzes glucosinolates to form…”
Get full text

Iranian centers of excellence in medical sciences: A qualitative study to analyze the current state and design of a future roadmap by Damari, Behzad, Kamrava, Seyed Kamran, Kazemi-Asl, Siamak, Rostamigooran, Narges

“…Background: Due to the law for the fifth development plan and Iran’s 20- year economic perspective, Centers of Excellence (COEs) were expected to upgrade the…”
Get full text

Iranian centers of excellence in medical sciences: A qualitative study to analyze the current state and design of a future roadmap by Damari, Behzad, Kamrava, Seyed Kamran, Kazemi-Asl, Siamak, Rostamigooran, Narges

“…Due to the law for the fifth development plan and Iran's 20- year economic perspective, Centers of Excellence (COEs) were expected to upgrade the level of…”
Get full text

Designing two models for comprehensive center of excellence and center of excellence in the field of medical sciences in Iran by Hadi Khoshmohabat, Parisa Mehdizadeh, Mehdi Ebrahimnia, Siamak Kazemi Asl, Nooredin Dopeykar

“…Background: Despite exist several centers of excellence in the various medical field in the country, most of them lack a single procedure and organizational…”
Get full text

Determining Educational Needs of Educational and Research Centers of Excellence: Road Map of Scientific and Educational Centers of Excellence in Medical Sciences by Behzad Damari, Kamran Kamrava, Siamak Kazemi-Asl, Nader Momtaz-Manesh, Abbas VosooghMoghaddam, Hossein Mirzaei

“…Background and Objectives: According to the compilation and approval of the strategic map of the country’s centers of excellence in 2011, Achieving the…”
Get full text

Immunogenicity of hepatitis B vaccine in multi-transfused thalassemic patients with and without hepatitis C infection: a comparative study with healthy controls by Froutan-Pishbijari, Hossein, Ghofrani, Hadi, Mirmomenm, Shahram, Kazemi-Asl, Siamak, Nassiri-Toosi, Mohsen, Farahvash, Mohammad-Jafar, Toroghi, Hossein Hashemi, Aminian, Keyvan, Mansour-Ghanaei, Fariborz, Bagherzadeh, Amir-Hossein

“…Hepatitis C virus (HCV) infection is highly prevalent in thalassemic patients. This may decrease serum antibody response to hepatitis B virus (HBV) vaccine…”
Get more information